Tunisia looks to Russia, Pfizer for vaccination program

Tunisian authorities have given emergency authorization to use Russia’s Sputnik-V coronavirus vaccine, but haven’t yet ordered any doses

It’s expected to get its first deliveries — 93,000 initial doses from Pfizer-BioNTech — in mid-February, followed by about 600,000 doses of the AstraZeneca-Oxford vaccine, according to the director of the Pasteur Institute in Tunis, Dr. Hachemi Louzir, who is overseeing Tunisia’s vaccination program.

Those are part of a broader arrangement with the COVAX global vaccine program for developing countries and the African CDC that Tunisia hopes will bring in as many as 7 million vaccine doses in the coming months, Louzir said.

In addition, Tunisia struck a bilateral deal this week with Pfizer-BioNTech for 2 million doses, according to Louzir, who is overseeing Tunisia’s vaccination program.

After Algeria struck a deal last year for the Sputnik vaccine and Morocco made an early agreement with China’s Sinopharm, Tunisia is now in negotiations to acquire the Russian vaccine, Louzir said.

Tunisia hopes to vaccinate 50% of its population of some 11 million people by next summer. Louzir estimated the overall cost of Tunisia’s vaccination program at $100 million.

Tunisia has reported more than 7,000 virus-related deaths and more than 213,000 infections, according to a tally by Johns Hopkins University.


Follow AP coverage of the coronavirus pandemic at:




Top Stories

Top Stories

Top Stories

Top Stories

ABC News Live

ABC News Live

24/7 coverage of breaking news and live events